dividends
NV
NYSE · NVO
Novo Nordisk A/S
Healthcare · Drug Manufacturers - General
$42.53
Down-$0.92 (-2.12%)
Updated Sep 16, 2026, 12:06 PM
SID Score
6.3/10
Composite research score
Smart Money
57/100
Neutral
- Market cap
- 223.45B
- P/E ratio
- 12.76
- Dividend yield
- 3.96%
- 52-week range
- $35.12 – $64.16
- Volume
- 8.86M
- Avg. volume
- 16.69M
Price performance
NVO price history
1M range · 20 trading sessions · Daily adjusted prices
NVO closed at $42.53 after 20 trading sessions, down 6.96% for the selected period.
- Last close
- $42.53
- Period change
- -6.96%
- Period low
- $42.53
- Period high
- $48.66
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 15, 2026 | $42.725 | $43.00 | $42.40 | $42.53 | 8.86M |
| Sep 14, 2026 | $43.66 | $43.71 | $43.0701 | $43.45 | 6.56M |
| Sep 11, 2026 | $43.195 | $43.4951 | $42.7216 | $43.07 | 11.03M |
| Sep 10, 2026 | $44.60 | $44.82 | $44.01 | $44.01 | 6.58M |
| Sep 9, 2026 | $45.00 | $45.395 | $44.52 | $44.56 | 8.83M |
| Sep 8, 2026 | $45.58 | $45.91 | $45.145 | $45.16 | 10.35M |
| Sep 4, 2026 | $46.35 | $46.74 | $46.0417 | $46.60 | 6.22M |
| Sep 3, 2026 | $47.99 | $48.00 | $46.565 | $47.51 | 8.77M |
| Sep 2, 2026 | $46.05 | $47.005 | $45.91 | $46.77 | 13.6M |
| Sep 1, 2026 | $45.80 | $46.16 | $45.065 | $45.12 | 9.36M |
| Aug 31, 2026 | $45.28 | $45.61 | $44.95 | $45.33 | 7.61M |
| Aug 28, 2026 | $46.17 | $46.21 | $45.405 | $45.61 | 8.5M |
| Aug 27, 2026 | $45.97 | $46.33 | $45.70 | $46.26 | 13.02M |
| Aug 26, 2026 | $47.80 | $48.04 | $46.87 | $47.19 | 8.88M |
| Aug 25, 2026 | $47.84 | $48.66 | $47.56 | $48.66 | 15.53M |
| Aug 24, 2026 | $47.09 | $47.30 | $46.565 | $46.92 | 9.67M |
| Aug 21, 2026 | $46.35 | $47.165 | $46.34 | $46.74 | 10.91M |
| Aug 20, 2026 | $46.89 | $46.90 | $46.11 | $46.14 | 9.67M |
| Aug 19, 2026 | $46.01 | $47.195 | $45.841 | $46.48 | 19.51M |
| Aug 18, 2026 | $44.91 | $46.065 | $44.76 | $45.71 | 12.09M |
Latest NVO news
The latest Smart Investors Daily articles mentioning NVO.
Stock researchResearch & News · SEC Filings
Loading stock research…